Anhydrovinblastine is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of vinblastine and vincristine, which are potent anticancer drugs. These drugs are widely used in chemotherapy to treat various types of cancers, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, breast cancer, and lung cancer. The compound plays a crucial role in the production process, enabling the development of these life-saving medications. Its application underscores its importance in advancing cancer treatment and improving patient outcomes.